The UK Health Security agency publishes information on the toxic effects of asbestos. It gives a clear and concise summary of asbestos’s behaviour in the body, the exposure pathways, and the differing impacts based on fibre type.
The full article is here, and below is a concise summary.
Short asbestos fibres tend to lodge in the upper respiratory tract, where they are more readily removed by the natural mucociliary mechanism. Conversely, longer fibres travel deeper into the alveolar regions of the lungs and exhibit slower clearance, leading to prolonged retention and increased health risks. Additionally, some inhaled fibres may be swallowed during mucociliary transport.
The toxicity of asbestos varies by fibre type. Chrysotile (serpentine-type) fibres are typically less damaging than amphibole-type fibres, which are more persistent in lung tissue and therefore more dangerous.
Exposure to asbestos principally occurs via inhalation, with a secondary—but possible—route being ingestion, especially as the body attempts to clear inhaled fibres.
Acute exposure may cause local irritation, particularly through inhalation. Dermal or ocular contact can result in superficial tissue irritation or benign skin lesions if fibres penetrate the skin.
In contrast, chronic or repeated exposure is associated with severe and long-term health outcomes. These include asbestosis, lung cancer, and mesothelioma—diseases that may manifest decades after initial exposure.